Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
Kirsten Trayner, Andrew McAuley, Norah Palmateer, Alan Yeung, David Goldberg, Megan Glancy, Carole Hunter, Trina Ritchie, Julie Craik, Fiona Raeburn, Stuart McTaggart, Lee Barnsdale, John Campbell, Samantha Shepherd, Amanda Bradley-Stewart, Rory Gunson, Kate Templeton, Sharon Hutchinson
COVID-19 has likely affected the delivery of interventions to prevent blood-borne viruses (BBVs) among people who inject drugs (PWID). We examined the impact of the first wave of COVID-19 in Scotland on: 1) needle and syringe provision (NSP), 2) opioid agonist therapy (OAT) and 3) BBV testing.